(Q69592951)

English

The impact of stage and treatment modality on the likelihood of second malignancies and hematopoietic disorders in Hodgkin's disease

scientific article published on 01 March 1989

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2710953

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2710953%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 October 2019

title

The impact of stage and treatment modality on the likelihood of second malignancies and hematopoietic disorders in Hodgkin's disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2710953

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2710953%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 October 2019

author name string

N P Mendenhall

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2710953

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2710953%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 October 2019

J J Shuster

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2710953

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2710953%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 October 2019

R R Million

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2710953

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2710953%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 October 2019

publication date

1 March 1989

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2710953

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2710953%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 October 2019

published in

Radiotherapy and Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2710953

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2710953%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 October 2019

volume

14

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2710953

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2710953%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 October 2019

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2710953

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2710953%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 October 2019

page(s)

219-229

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2710953

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2710953%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 October 2019

Identifiers

DOI

10.1016/0167-8140(89)90170-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2710953

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2710953%20AND%20SRC:MED&resulttype=core&format=json

retrieved

3 October 2019

PubMed publication ID

2710953

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2710953

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2710953%20AND%20SRC:MED&resulttype=core&format=json

(Q69592951)

The impact of stage and treatment modality on the likelihood of second malignancies and hematopoietic disorders in Hodgkin's disease

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)